Delivery Order SPE2DB24D2100-SPE2DB24FBCHT

Award Date 7/9/24
Potential Completion Date 7/10/24
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB24FBCHT
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, is for the supply of 4,565,098,969 units of the cancer medication Azacitidine 100 mg vials. The $1,012.34 delivery order contract has a completion date of July 10, 2024 and was awarded on July 9, 2024 by the Defense Logistics Agency (DLA), a defense agency under the Department of Defense (DoD).

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide. This latest contract award is likely a specific order placed under that IDC. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. No set-aside designation was used for this contract award.

Generated 10/8/24, 9:24 AM